PGL4001 Versus GnRH-agonist in Uterine Myomas

NCT00740831 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Myomas

Interventions

DRUG: PGL4001
DRUG: leuprorelin

Sponsor

PregLem SA